Peyronie's disease resulting in shorter and curved erections occurs more commonly than the 1% to 2% of the population related in textbooks. Patients with the problem may be embarrassed to come forward, or the angulation of the erection-although uncomfortable-may not prohibit intercourse. But with more open discussion of sexuality in all forms of the media, more men are coming forward for treatment of sexual problems. Past medical treatments have been unsuccessful in restoring a straight erection in such patients. Reports of newer treatments such as intralesional verapamil and collagenase have been inconsistent and must stand the test of time.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.